ASLAN Pharmaceuticals Limited, a biopharmaceutical company, is focused on transforming the lives of patients through the development of immunology treatments. The company's clinical portfolio consists of two therapies, ASLAN004 and ASLAN003, which are being developed to treat immunology and autoimmune conditions. ASLAN Pharmaceuticals has partnerships with Almirall, Array BioPharma, and CSL Limited, and a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics.